Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. Developing and petro-rich nations are pushing world demand for pharmaceuticals. Pharmacists are favoring OTCs, and are a driving force behind a new class of 'behind the counter' (BTC) drugs. The aging of the population and an increase in medical conditions generally continues to bode well for OTC products. For the purpose of this study, Kalorama Information has divided products into five general segments:
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives. The OTC market is vast with many competitors. The following main competitors are profiled in this report:
Related Reports: The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)Oct 1, 2009 - KLI2435380 - $3,500.00 2009 Worldwide Diagnostics Market Research Bundle Oct 1, 2009 - KLI2401913 - $5,995.00 The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets Oct 1, 2009 - KLI2384194 - $3,995.00 Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition Sep 1, 2009 - KLI2284095 - $3,500.00 The World Market for Biosimilars and the Potential for US Follow-on Biologics Aug 1, 2009 - KLI2402283 - $3,700.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition May 1, 2009 - KLI2218043 - $3,995.00 Rx to OTC Switches 2009 May 1, 2009 - KLI2196300 - $3,500.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition May 1, 2009 - KLI2123150 - $3,995.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Markets, 3rd Edition
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)
|
|||||||||
Email a colleague
Printer format
Order by fax|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|
